ivermectol
| Product dosage: 12mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $6.71 | $67.08 (0%) | 🛒 Add to cart |
| 20 | $5.71 | $134.15 $114.13 (15%) | 🛒 Add to cart |
| 30 | $5.37 | $201.23 $161.19 (20%) | 🛒 Add to cart |
| 60 | $5.06 | $402.46 $303.35 (25%) | 🛒 Add to cart |
| 90 | $4.95 | $603.69 $445.51 (26%) | 🛒 Add to cart |
| 120 | $4.90 | $804.92 $587.68 (27%) | 🛒 Add to cart |
| 180 | $4.85
Best per pill | $1207.39 $873.00 (28%) | 🛒 Add to cart |
Synonyms | |||
I remember when we first started getting requests for compounded ivermectin preparations back in early 2020 - we called our formulation “Ivermectol” to distinguish it from the veterinary products that were causing so much confusion. The pharmacy team and I had numerous late-night debates about whether we should even be compounding this, given the limited evidence for COVID-19 at the time.
## 1. Introduction: What is Ivermectol? Its Role in Modern Medicine
Ivermectol refers to pharmaceutical-grade ivermectin formulations prepared for human use, typically in compounding pharmacies under specific protocols. Unlike the veterinary formulations that gained notoriety during the pandemic, Ivermectol represents the legitimate medical application of ivermectin that’s been used safely for decades in tropical medicine.
The drug itself isn’t new - Japanese scientist Satoshi Ōmura won the Nobel Prize in 2015 for discovering ivermectin, which has revolutionized treatment of parasitic diseases like river blindness and lymphatic filariasis. What’s changed is the context of use and the public understanding of its limitations and appropriate applications.
## 2. Key Components and Bioavailability Ivermectol
The standard Ivermectol formulation contains ivermectin as the active pharmaceutical ingredient, typically in 3mg or 6mg tablets. The bioavailability varies significantly with food - taking it with a high-fat meal can increase absorption by 2.5 times compared to fasting conditions. This is crucial for dosing considerations that many patients don’t appreciate.
We’ve found that the particle size and excipient composition significantly affect dissolution rates. One of our early formulation errors involved using a standard filler that actually reduced bioavailability by nearly 40% compared to the reference product. Took us three months of testing to identify the issue.
## 3. Mechanism of Action Ivermectol: Scientific Substantiation
The primary mechanism involves binding to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, causing increased cell membrane permeability to chloride ions, hyperpolarization, and paralysis of the parasites. In simpler terms, it essentially paralyzes and kills certain parasites without significantly affecting human cells.
The proposed antiviral mechanisms are more controversial. Some research suggests ivermectin may inhibit importin α/β-mediated nuclear transport, potentially reducing viral replication for some viruses. However, the concentrations needed for this effect in vitro are generally much higher than what’s achievable with standard dosing in humans.
## 4. Indications for Use: What is Ivermectol Effective For?
Ivermectol for Parasitic Infections
This is the established, evidence-based use. Strongyloidiasis, onchocerciasis, lymphatic filariasis, scabies, and ascariasis all have robust clinical evidence supporting ivermectin use. The WHO includes it on their List of Essential Medicines specifically for these indications.
Ivermectol for COVID-19
This is where things get complicated. Early in vitro studies showed promise, but subsequent clinical trials and meta-analyses have largely failed to demonstrate significant benefits for COVID-19 treatment or prevention. The NIH COVID-19 Treatment Guidelines recommend against its use outside clinical trials.
Ivermectol for Other Viral Conditions
The evidence here is even thinner. While some practitioners have experimented with it for everything from influenza to dengue, the clinical data simply doesn’t support these uses currently.
## 5. Instructions for Use: Dosage and Course of Administration
For parasitic infections, dosing is weight-based and indication-specific:
| Condition | Dosage | Frequency | Duration |
|---|---|---|---|
| Strongyloidiasis | 200 mcg/kg | Single dose | One day |
| Onchocerciasis | 150 mcg/kg | Single dose | Repeat every 6-12 months |
| Scabies | 200 mcg/kg | Single dose | May repeat in 2 weeks |
The COVID-19 dosing that became popular (often daily or weekly) lacks evidence and carries unknown safety risks with prolonged use.
## 6. Contraindications and Drug Interactions Ivermectol
Significant contraindications include hypersensitivity to ivermectin and conditions that might increase blood-brain barrier permeability. The interaction with warfarin is particularly important - we’ve seen several cases of elevated INR values requiring dosage adjustments.
Pregnancy category C means benefits should outweigh risks. I recall one difficult case where a woman with disseminated strongyloidiasis needed treatment during her second trimester - we consulted with infectious disease, maternal-fetal medicine, and the patient before proceeding.
## 7. Clinical Studies and Evidence Base Ivermectol
The parasitic disease evidence is extensive and compelling. The COVID-19 evidence, however, tells a cautionary tale about how early promising results can fail to replicate. The TOGETHER trial, one of the largest randomized studies, found no significant benefit for early COVID-19 treatment. Similarly, the PRINCIPLE trial showed no reduction in hospitalization.
What’s interesting is how the scientific process worked here - initial enthusiasm based on mechanistic plausibility and early studies gave way to more rigorous, larger trials that provided clearer answers.
## 8. Comparing Ivermectol with Similar Products and Choosing a Quality Product
The key distinction is between pharmaceutical-grade human formulations and veterinary products. The latter may contain different excipients, have different purity standards, and often come in concentrations intended for large animals. We’ve seen several cases of toxicity from people taking veterinary formulations.
Quality markers include proper manufacturing documentation, batch testing, and clear labeling of strength and expiration dates. The compounding pharmacy should follow USP <795> guidelines if preparing custom formulations.
## 9. Frequently Asked Questions (FAQ) about Ivermectol
What is the recommended course of Ivermectol to achieve results?
For approved parasitic indications, typically one to two doses as specified in treatment guidelines. Not recommended for COVID-19 outside clinical trials.
Can Ivermectol be combined with other medications?
Important interactions exist with warfarin, certain benzodiazepines, and other CYP3A4 substrates. Always consult a healthcare provider about potential interactions.
Is Ivermectol safe for children?
Yes, for appropriate indications and with weight-based dosing. The WHO includes it in pediatric treatment programs for certain parasitic diseases.
## 10. Conclusion: Validity of Ivermectol Use in Clinical Practice
Ivermectol has a well-established role in treating specific parasitic infections where the risk-benefit profile is clearly favorable. For other proposed uses, particularly COVID-19, the current evidence doesn’t support widespread use. The challenge for clinicians has been separating legitimate medical use from misinformation-driven demand.
I’ll never forget Mrs. Henderson, 68-year-old with chronic lymphocytic leukemia who developed disseminated strongyloidiasis after chemotherapy. Her immunocompromised state made the infection life-threatening. We used Ivermectol following infectious disease protocols - two doses one week apart. The improvement was dramatic. Her eosinophil count normalized within two weeks, and she could resume her cancer treatment.
Contrast that with the dozens of healthy people who came demanding Ivermectol for COVID-19 prevention during the delta wave. We had to have some difficult conversations explaining why we wouldn’t prescribe it for that purpose, especially when they’d already obtained veterinary formulations from farm supply stores. Saw several cases of gastrointestinal upset and dizziness from inappropriate self-medication.
The most challenging aspect was the polarization within our own medical staff. Dr. Wilkins in family medicine was convinced it worked for COVID based on some early studies, while our infectious disease team was adamant about waiting for better evidence. The tension affected our working relationships for months.
What surprised me was discovering that some patients were taking massive doses - one man admitted to taking 30mg daily for “prevention.” His liver enzymes were elevated, though we couldn’t definitively attribute it to the ivermectin. The desperation people felt during the pandemic led to some frightening medication practices.
Follow-up with Mrs. Henderson has been encouraging - eighteen months out, no recurrence of strongyloidiasis. She sends Christmas cards to the pharmacy team every year. Meanwhile, many of the COVID “believers” have quietly moved on to other unproven treatments. The whole experience taught me how important it is to separate the legitimate medical uses of a drug from the social media hype cycles.